1. Market Research
  2. > Pharmaceutical Market Trends
DNA Repair Drugs: Global Markets

DNA Repair Drugs: Global Markets

  • February 2022
  • 112 pages
  • ID: 6229573
  • Format: PDF
  • BCC Research

Summary

Table of Contents

Report Scope:
This report provides an in-depth examination of the healthcare industry, with a particular emphasis on global market trend analysis.The report’s goal is to provide an overview of the market for DNA repair drugs, as well as market segmentation by type, application and geography.

During the forecast period, the market for DNA repair drugs is expected to grow rapidly. The report provides key statistics on the market status of the leading players in the DNA repair drug market, as well as key market trends and opportunities.

Report Includes:
- 20 data tables and 20 additional tables
- A brief general outlook of the global markets for DNA repair drugs within the biotech industry
- Analyses of the global market trends, with data from 2020 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Discussion of major factors driving the growth of global DNA repair drugs market, industry structure, regulatory scenario and penetration of technologies within the marketplace
- Highlights of key market dynamics (DROs), current trends and emerging applications, federal regulations and opportunity assessment of next generation technologies anticipated to drive the progress of this market
- Evaluation of current market size and revenue forecast for DNA repair drugs in dollar value terms, and corresponding market share analysis by technology type, application and region
- Assessment of new developments relate to DNA research and type classification, their improvement techniques, focused scene investigation and patterns of advancements
- Insight into the R&D spendings in the pharmaceutical industry, approval of new drugs, projected revenues and cost analyses
- Emphasis on the SARS-CoV-2 Infection Impairs on DNA repair and inhibits
- Profile descriptions of the leading market players, including AbbVie, Bayer AG, Eli Lilly and Co., Johnson & Johnson, Novartis and Sanofi

Summary:
DNA repair is a set of processes that a cell uses to detect and repair damage to the DNA molecules that encode its genome.DNA repair drugs are used to repair damaged DNA as well as to treat cancer.

Damage to DNA causes genetic disorders; however, the human body has mechanisms in place to correct the DNA sequence. PARP inhibitors and other DNA repair drugs aid in the treatment of diseases caused by genetic mutations.

The market is favored by advances in oncology research for discovering underlying molecular mechanisms of cancerous cells in order to develop novel therapeutics.Furthermore, the increasing number of advanced cancer cases worldwide has significantly increased the need for developing DNA damage response drugs to address cancer’s unmet needs.

These drugs have unrivaled potential for improving cancer survival rates by providing a selective and well-tolerated treatment approach.

Over the forecast period, the increasing incidence of cancer is expected to drive the growth of the global market for DNA repair drugs.According to the World Cancer Research Fund International’s 2020 report, breast cancer was responsible for the second highest number of cancer cases (2,261,419 new cases) worldwide in 2020.

According to Globocan, 45.4% of new cases of breast cancer in the Asia Pacific were registered in 2020.

Furthermore, increasing drug approval by key players in order to meet demand for efficient therapeutics is expected to drive market growth over the forecast period. Talazoparib (Talzenna) was approved by the U.S. Food and Drug Administration (FDA) in October 2018 for the treatment of HER2 positive patients (negative locally advanced or metastatic breast cancer).

Delays in regulatory approvals, on the other hand, cause a delay in product marketing, which can have a negative impact on a manufacturer’s revenues. Similarly, a delay in post-approval of a drug product for another therapeutic indication increases clinical trial costs and has the potential to affect the labeling and approval status of currently marketed products.

The table belowshows the global market for DNA repair drugs, by major application.The 2021 estimated market of REDACTED is forecast to grow at a REDACTED compound annual growth rate (CAGR) to reach REDACTED through 2026.

Market drivers include the rising worldwide prevalence of cancer, a favorable reimbursement scenario, increasing oncology R&D expenditures, and an increase in the adoption of precision medicine in cancer treatment.

Due to the increasing prevalence of cancer and the increasing demand for DNA repair drugs in this region, the North American market for DNA repair drugs is expected to grow rapidly. According to the American Cancer Society, approximately 21,410 women in the U.S.were diagnosed with ovarian cancer in 2021, with 13,770 women dying from the disease. Ovarian cancer is the fifth leading cause of cancer death in women, accounting for more fatalities than any other cancer of the female reproductive system.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $ 3500
  • May 2022
  • 61 pages

Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Muscarinic Acetylcholine Recepto ...

  • World
  • Pharmaceutical
  • Therapy
  • Industry analysis
  • Diagnostic Imaging Density
  • Drug Approval

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on